---
title: "Latch | 8-K: FY2025 Revenue: USD 70.12 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281183602.md"
datetime: "2026-03-31T12:08:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281183602.md)
  - [en](https://longbridge.com/en/news/281183602.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281183602.md)
generator: "portal-rs"
---

# Latch | 8-K: FY2025 Revenue: USD 70.12 M

Revenue: As of FY2025, the actual value is USD 70.12 M.

#### Financial and Operational Highlights for Latch, Inc. (Year Ended December 31, 2025)

#### Segment Revenue

-   Software revenue for Latch, Inc. was $22.1 million, an increase of $1.9 million or 9% year-over-year .

#### Total Revenue

-   Total revenue for Latch, Inc. reached $70.1 million, marking a $13.5 million or 24% year-over-year increase .

#### Operational Metrics

-   Operating expenses for Latch, Inc. were $79.6 million, representing a $4.8 million or 6% year-over-year reduction .
-   Net loss for Latch, Inc. was - $53.7 million, which is a $3.8 million or 7% year-over-year improvement .
-   Excluding a goodwill impairment, operating expenses would have been $63.0 million, a $21.4 million or 25% year-over-year improvement .
-   Adjusted EBITDA (non-GAAP) for Latch, Inc. was - $27.1 million, showing an $8.9 million or 25% year-over-year improvement .

#### Cash Flow

-   No specific operating cash flow or free cash flow metrics were provided in the reference .

#### Unique Metrics

-   The net loss was negatively impacted by non-cash items, including a $16.6 million goodwill impairment and a $4.9 million inventory-related write-off .

#### Outlook / Guidance

-   The provided reference does not contain specific financial outlook or guidance for future periods . It includes a cautionary note regarding forward-looking statements but no quantifiable future targets or predictions .

### Related Stocks

- [LTCH.US](https://longbridge.com/en/quote/LTCH.US.md)

## Related News & Research

- [Trinity Biotech agrees in principle to take minority stake in Latch Medical](https://longbridge.com/en/news/293466466.md)
- [Latch Q2 FY26 net loss narrows 12.1% to $6.9 million; revenue falls 18.1% to $15.62 million](https://longbridge.com/en/news/295405172.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**